“…First, we excluded 239 duplicates, then an additional 323 studies after screening the titles and abstracts; subsequently, 61 studies remained to undergo full-text review. Finally, we included 26 studies with 7,317 patients in the final analysis ( Lattanzi et al, 2016 , 2017 , 2018 ; Wang et al, 2016 ; Giede-Jeppe et al, 2017 ; Seabra et al, 2017 ; Sun et al, 2017 ; Tao et al, 2017 ; Fan et al, 2018 ; Qi et al, 2018 ; Wang F. et al, 2018 , 2019 ; Zhang et al, 2018a , b , 2019a , b , 2019c ; Guo et al, 2019 ; Pektezel et al, 2019 ; Qin et al, 2019 ; Wang Z. et al, 2019 ; Chen et al, 2020 ; Fonseca et al, 2021 ; Menon et al, 2021 ; Mohamed et al, 2021 ; Radu et al, 2021 ), of which 14 studies reported the prognostic value of NLR for poor outcome, 12 studies reported the prognostic value of NLR for mortality, four studies reported the prognostic value of NLR for hematoma expansion, and three studies reported the prognostic value of NLR for neurological deterioration, respectively.…”